Akso Health Group Sponsored ADR (AHG)
NASDAQ:AHG

Akso Health Group Sponsored ADR (AHG) Income Statement

144 Followers

Akso Health Group Sponsored ADR Income Statement

Last quarter (Q ), Akso Health Group Sponsored ADR's total revenue was $―, a decrease of ― from the same quarter last year. In Q, Akso Health Group Sponsored ADR's net income was $―. See Akso Health Group Sponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 23Mar 22Mar 21Mar 20Mar 19
Total Revenue
-$ 14.72M$ 5.20M$ 1.75M$ 6.91M$ 61.33M
Credit Losses Provision
------
Non Interest Expense
-$ 27.79M$ 9.21M---
Incomefrom Associatesand Other Participating Interests
------
Special Income Charges
-$ -12.25M$ -6.15M$ -1.60M$ -29.19M$ 0.00
Pretax Income
-$ -13.07M$ -4.01M$ -31.07M$ -46.87M$ 7.41M
Tax Provision
-$ 17.55K$ 92.82K$ 482.98K$ 489.95K$ 1.87M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
-$ -1.36M$ -16.85M$ -34.83M$ -71.20M$ 5.53M
Basic EPS
-$ -0.04$ -0.56$ -0.71$ -4.38$ 0.33
Diluted EPS
-$ -0.04$ -0.56$ -0.71$ -4.38$ 0.30
Basic Average Shares
-$ 68.60M$ 59.61M$ 48.84M$ 16.25M$ 16.23M
Diluted Average Shares
-$ 68.60M$ 59.61M$ 48.84M$ 16.25M$ 17.64M
Dividend Per Share
---$ 0.00$ 0.00$ 0.81
Reported Normalized Basic E P S
-----$ 0.75
Reported Normalized Diluted E P S
-----$ 0.66
Rent Expense Supplemental
------
Interest Income After Provision For Loan Loss
-$ -4.96K$ -804.14K---
Net Income From Continuing And Discontinued Operation
-$ -1.36M$ -16.85M$ -34.83M$ -71.20M$ 5.53M
Normalized Income
-$ -10.32M-$ -30.35M$ -25.47M$ 5.53M
Total Money Market Investments
------
Ebit
---$ -28.91M$ -44.37M$ 7.41M
Ebitda
---$ -28.90M$ -44.25M$ 7.81M
Currency in USD

Akso Health Group Sponsored ADR Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis